ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
DNA synthesis company Twist Bioscience has raised $50 million from private investors, bringing its fundraising to $259 million since launching in 2013. The new funds will help expand the firm’s reach in drug discovery and data storage in DNA. In February, researchers from Microsoft and the University of Washington encoded 200 MB from 35 digital data files into more than 13 million DNA oligonucleotides of about 150 bases each, all synthesized by Twist.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter